Grupo para la caracterización molecular de las neoplasias hematológicas
King's College Hospital
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de King's College Hospital (2)
2015
-
Conversion, correction, and international scale standardization: Results from a multicenter external quality assessment study for BCR-ABL1 testing
Archives of Pathology and Laboratory Medicine, Vol. 139, Núm. 4, pp. 522-529
2013
-
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): A randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 14, Núm. 11, pp. 1055-1066